Market Cap Weighted Index
Search documents
Is FlexShares Credit-Scored US Corporate Bond ETF (SKOR) a Strong ETF Right Now?
ZACKS· 2026-01-09 12:21
Core Insights - The FlexShares Credit-Scored US Corporate Bond ETF (SKOR) offers broad exposure to the Investment Grade Corporate Bond ETFs category and debuted on 11/12/2014 [1] - SKOR has amassed assets over $643.67 million, positioning it as an average-sized ETF in its category [5] - The fund seeks to match the performance of the Northern Trust Credit-Scored US Corporate Bond Index, which focuses on investment-grade bonds with favorable valuations [6] Fund Management and Costs - Managed by Flexshares, SKOR has an annual operating expense ratio of 0.15%, which is competitive within its peer group [7] - The fund's 12-month trailing dividend yield is 4.69% [7] Holdings and Sector Exposure - SKOR's top 10 holdings account for approximately 4.29% of its total assets, with cash making up about 1.01% of the fund [8][9] - The fund is transparent about its holdings, disclosing them daily [8] Performance Metrics - As of 01/09/2026, SKOR has added roughly 0.03% year-to-date and is up approximately 8.08% over the past year [10] - The fund has traded between $47.30 and $49.50 in the last 52 weeks [10] - SKOR has a beta of 0.23 and a standard deviation of 3.98% over the trailing three-year period, indicating a high-risk profile [11] Alternatives and Market Position - SKOR is positioned as a reasonable option for investors seeking to outperform the Investment Grade Corporate Bond ETFs segment [12] - Other alternatives include the State Street SPDR Portfolio Intermediate Term Corporate Bond ETF (SPIB) and the Vanguard Intermediate-Term Corporate Bond ETF (VCIT), which have significantly larger asset bases [13] - SPIB has an expense ratio of 0.04% and VCIT charges 0.03%, making them cheaper options [13]
Is WisdomTree International High Dividend ETF (DTH) a Strong ETF Right Now?
ZACKS· 2026-01-05 12:20
Core Insights - The WisdomTree International High Dividend ETF (DTH) is designed to provide broad exposure to the Broad Developed World ETFs category and was launched on June 16, 2006 [1] Fund Overview - DTH is managed by WisdomTree and has accumulated over $527.29 million in assets, categorizing it as an average-sized ETF in its segment [5] - The fund aims to match the performance of the WisdomTree International High Dividend Index, which is fundamentally weighted and focuses on companies with high dividend yields [6] Cost and Performance - DTH has an annual operating expense ratio of 0.58% and a 12-month trailing dividend yield of 3.78% [7] - Year-to-date, DTH has increased by approximately 0.64% and has risen about 43.42% over the last 12 months, with trading prices ranging from $37.33 to $51.94 in the past 52 weeks [9] Risk and Diversification - The fund has a beta of 0.58 and a standard deviation of 13.50% over the trailing three-year period, indicating it is a medium-risk investment [10] - DTH holds about 584 stocks, effectively diversifying company-specific risk [10] Alternatives - Other ETFs in the same space include iShares MSCI EAFE ETF (EFA) and iShares Core MSCI EAFE ETF (IEFA), which have significantly larger assets of $71.19 billion and $164.4 billion respectively, with lower expense ratios of 0.32% and 0.07% [12]
Is State Street SPDR S&P Semiconductor ETF (XSD) a Strong ETF Right Now?
ZACKS· 2025-11-21 12:21
Core Insights - The State Street SPDR S&P Semiconductor ETF (XSD) is a smart beta ETF launched on January 31, 2006, designed to provide broad exposure to the Technology ETFs category [1] - The fund has accumulated over $1.46 billion in assets, making it one of the larger ETFs in the Technology sector [5] - XSD seeks to match the performance of the S&P Semiconductor Select Industry Index, which represents the semiconductor sub-industry portion of the S&P Total Markets Index [6] Fund Management and Costs - Managed by State Street Investment Management, XSD has annual operating expenses of 0.35%, positioning it as one of the least expensive options in its category [7] - The fund offers a 12-month trailing dividend yield of 0.25% [7] Sector Exposure and Holdings - The ETF has a heavy allocation to the Information Technology sector, representing 100% of its portfolio [8] - Rigetti Computing Inc (RGTI) constitutes approximately 7.24% of total assets, with Intel Corp (INTC) and Advanced Micro Devices (AMD) also among the top holdings [9] - The top 10 holdings account for about 36.31% of XSD's total assets under management [9] Performance Metrics - As of November 21, 2025, the ETF has gained approximately 16.11% and was up about 24.97% year-to-date [11] - XSD has traded between $160.63 and $353.65 over the past 52 weeks, with a beta of 1.64 and a standard deviation of 36.55% for the trailing three-year period, indicating high risk [11] Alternatives in the Market - Other ETFs in the semiconductor space include iShares Semiconductor ETF (SOXX) and VanEck Semiconductor ETF (SMH), with assets of $14.83 billion and $33.66 billion respectively [13] - SOXX has an expense ratio of 0.34% while SMH charges 0.35%, providing investors with alternative options [13]
Is State Street SPDR Russell 1000 Low Volatility Focus ETF (ONEV) a Strong ETF Right Now?
ZACKS· 2025-11-12 12:21
Core Insights - The State Street SPDR Russell 1000 Low Volatility Focus ETF (ONEV) debuted on December 2, 2015, and provides broad exposure to the Style Box - Large Cap Blend category of the market [1] Fund Overview - ONEV is managed by State Street Investment Management and has accumulated assets exceeding $579.23 million, positioning it as an average-sized ETF in its category [5] - The ETF aims to match the performance of the Russell 1000 Low Volatility Focused Factor Index, which includes large-cap U.S. equity securities with high value, high quality, and low size characteristics, focusing on low volatility [6] Cost Structure - ONEV has annual operating expenses of 0.20%, which is competitive with most peer products in the same space [7] - The fund's 12-month trailing dividend yield is 1.89% [7] Sector Exposure and Holdings - The ETF has a significant allocation in the Industrials sector, comprising approximately 20.7% of the portfolio, followed by Healthcare and Financials [8] - Cardinal Health Inc (CAH) represents about 1.33% of the fund's total assets, with the top 10 holdings accounting for around 9.38% of total assets under management [9] Performance Metrics - As of November 12, 2025, ONEV has increased by approximately 7.23% and is up about 1.3% year-to-date [11] - The ETF has traded between $114.16 and $135.42 over the past 52 weeks, with a beta of 0.89 and a standard deviation of 13.08% for the trailing three-year period [11] Alternatives - ONEV is considered a strong option for investors looking to outperform the Style Box - Large Cap Blend segment, with alternatives such as iShares Core S&P 500 ETF (IVV) and Vanguard S&P 500 ETF (VOO) available for consideration [12][13]
Is First Trust Multi Cap Growth AlphaDEX ETF (FAD) a Strong ETF Right Now?
ZACKS· 2025-10-28 11:21
Core Insights - The First Trust Multi Cap Growth AlphaDEX ETF (FAD) aims to provide broad exposure to the Style Box - All Cap Growth category and utilizes a smart beta strategy [1][5] - FAD is managed by First Trust Advisors and has accumulated over $365.95 million in assets, positioning it as an average-sized ETF in its category [5] - The ETF seeks to match the performance of the Nasdaq AlphaDEX Multi Cap Growth Index, which employs a stock selection methodology based on fundamental characteristics [6] Fund Characteristics - FAD has an annual operating expense ratio of 0.62%, which is competitive within its peer group, and a 12-month trailing dividend yield of 0.27% [7] - The ETF's largest sector allocation is in Industrials at approximately 24.1%, followed by Information Technology and Consumer Discretionary [8] - The top three individual holdings include Rocket Lab Corporation (0.64% of total assets), Vertiv Holdings Co, and Advanced Micro Devices, Inc., with the top 10 holdings comprising about 5.04% of total assets [9] Performance Metrics - Year-to-date, FAD has increased by roughly 20.33% and is up about 23.59% over the last 12 months as of October 28, 2025 [10] - The ETF has a beta of 1.15 and a standard deviation of 18.57% over the trailing three-year period, indicating a medium risk profile [10] - FAD holds approximately 677 stocks, effectively diversifying company-specific risk [10] Alternatives - Other ETFs in the same space include iShares Morningstar Growth ETF (ILCG) with $3.14 billion in assets and iShares Core S&P U.S. Growth ETF (IUSG) with $26.1 billion, both having an expense ratio of 0.04% [12] - Investors may consider traditional market cap weighted ETFs for potentially lower-risk options that aim to match returns in the Style Box - All Cap Growth segment [12]
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?
ZACKS· 2025-10-28 11:21
Core Insights - The First Trust NYSE Arca Biotechnology ETF (FBT) debuted on June 19, 2006, and offers broad exposure to the Health Care ETFs category [1] Fund Overview - FBT is sponsored by First Trust Advisors and has accumulated over $1.15 billion in assets, positioning it as one of the larger ETFs in the Health Care sector [5] - The ETF aims to match the performance of the NYSE Arca Biotechnology Index, which is an equal dollar weighted index focused on biotechnology companies [6] Cost Structure - The annual operating expenses for FBT are 0.54%, which is competitive within its peer group, and it has a 12-month trailing dividend yield of 0.62% [7] Sector Exposure and Holdings - FBT is fully allocated to the Healthcare sector, with Genmab A/s (adr) (GMAB) making up approximately 4.57% of total assets, followed by Alnylam Pharmaceuticals, Inc. (ALNY) and United Therapeutics Corporation (UTHR) [8][9] - The top 10 holdings constitute about 40.23% of the total assets under management [9] Performance Metrics - As of October 28, 2025, FBT has increased by approximately 14.7% year-to-date and 14.36% over the past year, with a trading range between $145.67 and $190.64 in the last 52 weeks [11] - The ETF has a beta of 0.65 and a standard deviation of 19.46% over the trailing three-year period, indicating a higher risk profile compared to peers [11] Alternatives - Other ETFs in the biotechnology space include iShares Biotechnology ETF (IBB) and SPDR S&P Biotech ETF (XBI), which have larger asset bases of $6.55 billion and $6.85 billion respectively, and lower expense ratios of 0.44% and 0.35% [13]
Is John Hancock Multifactor Mid Cap ETF (JHMM) a Strong ETF Right Now?
ZACKS· 2025-09-25 11:21
Core Insights - The John Hancock Multifactor Mid Cap ETF (JHMM) debuted on September 28, 2015, and provides broad exposure to the Mid Cap Blend category of the market [1] Fund Overview - JHMM is managed by John Hancock and has accumulated over $4.4 billion in assets, positioning it as one of the larger ETFs in its category [5] - The fund aims to match the performance of the John Hancock Dimensional Mid Cap Index, which includes U.S. companies ranked between the 200th and 951st largest by market capitalization [5] Cost Structure - The annual operating expenses for JHMM are 0.42%, which is competitive with most peer products [6] - The fund has a 12-month trailing dividend yield of 0.99% [6] Sector Allocation - JHMM's largest sector allocation is in Industrials, comprising approximately 20.5% of the portfolio, followed by Financials and Information Technology [7] - The top 10 holdings account for about 5.47% of the total assets under management, with United Rentals Inc (URI) being the largest individual holding at 0.73% [8] Performance Metrics - As of September 25, 2025, JHMM has gained about 8.21% year-to-date and approximately 8.35% over the past year [10] - The ETF has traded between $50.32 and $65.26 in the past 52 weeks, with a beta of 1.04 and a standard deviation of 17.64% over the trailing three-year period, indicating medium risk [10] Alternatives - Other ETFs in the mid-cap space include Vanguard Mid-Cap ETF (VO) and iShares Core S&P Mid-Cap ETF (IJH), which have significantly larger assets of $88.19 billion and $99.33 billion respectively [12] - VO has a lower expense ratio of 0.04%, while IJH charges 0.05%, making them potentially more attractive options for cost-conscious investors [12]
Is WisdomTree India Earnings ETF (EPI) a Strong ETF Right Now?
ZACKS· 2025-09-19 11:21
Core Insights - The WisdomTree India Earnings ETF (EPI) is a smart beta ETF that debuted on February 22, 2008, providing broad exposure to the Asia-Pacific (Emerging) ETFs category [1] - Smart beta ETFs aim to outperform traditional market cap weighted indexes by using alternative weighting strategies based on fundamental characteristics [2][3] - EPI has amassed over $2.9 billion in assets, making it one of the largest ETFs in the Asia-Pacific (Emerging) ETFs space [5] Fund Details - EPI is managed by WisdomTree and seeks to match the performance of the WisdomTree India Earnings Index, which measures the performance of profitable companies incorporated and traded in India [5][6] - The fund has an annual operating expense ratio of 0.84%, which is relatively high compared to other options in the market [7] - EPI has a 12-month trailing dividend yield of 0.27% [7] Holdings and Sector Exposure - The fund's holdings are primarily in US Dollar, accounting for approximately 116.47% of total assets, with significant positions in Wt India Investment Portfolio Inc and HDFC Bank Limited [8] - The top 10 holdings represent about 205.13% of total assets under management, indicating a concentrated investment strategy [9] Performance Metrics - As of September 19, 2025, EPI has added approximately 0.51% year-to-date but is down about -7.73% over the past year [11] - The ETF has traded between $40.08 and $50.82 in the last 52 weeks, with a beta of 0.48 and a standard deviation of 15.12% over the trailing three-year period, categorizing it as a medium-risk investment [11] Alternatives - Other ETFs in the space include Franklin FTSE India ETF (FLIN) and iShares MSCI India ETF (INDA), which have lower expense ratios and larger asset bases [12][13] - FLIN has $2.5 billion in assets with an expense ratio of 0.19%, while INDA has $9.45 billion with an expense ratio of 0.62% [13]
Is iShares International Equity Factor ETF (INTF) a Strong ETF Right Now?
ZACKS· 2025-09-15 11:21
Core Insights - The iShares International Equity Factor ETF (INTF) is a smart beta ETF launched on April 28, 2015, providing broad exposure to the Foreign Large Blend ETF category [1] Group 1: Smart Beta ETFs - Smart beta ETFs track non-cap weighted strategies, appealing to investors seeking to outperform the market by selecting stocks based on specific fundamental characteristics [3] - Traditional ETFs are based on market cap weighted indexes, which replicate market returns in a low-cost and transparent manner [2] Group 2: Fund Details - Managed by Blackrock, INTF has assets exceeding $2.41 billion, positioning it as an average-sized ETF in its category [5] - The fund aims to match the performance of the MSCI World ex USA Diversified Multi-Factor Index [5] - INTF has an annual operating expense of 0.16%, making it one of the cheaper options in the market [6] - The fund offers a 12-month trailing dividend yield of 2.75% [6] Group 3: Holdings and Performance - Novartis Ag (NOVN) is the largest holding at approximately 1.85%, followed by Asml Holding Nv (ASML) and Sap (SAP) [7] - The top 10 holdings constitute about 10.59% of INTF's total assets [8] - The ETF has gained approximately 27.02% year-to-date and 20.65% over the past year, with a trading range of $27.60 to $36.07 in the last 52 weeks [9] - INTF has a beta of 0.80 and a standard deviation of 15.75% over the trailing three-year period, indicating medium risk [10] Group 4: Alternatives - Other ETFs in the Foreign Large Blend segment include Vanguard Total International Stock ETF (VXUS) and Vanguard FTSE Developed Markets ETF (VEA), with VXUS having $105.43 billion in assets and VEA $175.94 billion [12] - VXUS has an expense ratio of 0.05% and VEA charges 0.03% [12]
Is First Trust Consumer Staples AlphaDEX ETF (FXG) a Strong ETF Right Now?
ZACKS· 2025-09-11 11:21
Core Viewpoint - The First Trust Consumer Staples AlphaDEX ETF (FXG) is a smart beta ETF that aims to provide broad exposure to the Consumer Staples sector, utilizing a modified equal-dollar weighted index to potentially outperform traditional passive indices [1][5][6]. Fund Overview - FXG was launched on May 8, 2007, and has accumulated assets exceeding $284.05 million, categorizing it as an average-sized ETF in the Consumer Staples sector [1][5]. - The fund is managed by First Trust Advisors and seeks to match the performance of the StrataQuant Consumer Staples Index before fees and expenses [5]. Investment Strategy - FXG employs the AlphaDEX screening methodology to select stocks from the Russell 1000 Index, aiming to identify those with better risk-return performance based on fundamental characteristics [6][3]. - The fund's operating expenses are 0.62%, making it one of the more expensive options in the ETF space, with a 12-month trailing dividend yield of 2.24% [7]. Sector Exposure and Holdings - The fund has a significant allocation to the Consumer Staples sector, representing 87.7% of the portfolio, with Healthcare and Materials as the next largest sectors [8]. - Pilgrim's Pride Corporation (PPC) is the largest holding at approximately 4.56% of total assets, followed by The Kraft Heinz Company (KHC) and Molson Coors Beverage Company (TAP). The top 10 holdings constitute about 40.2% of total assets [9]. Performance Metrics - Year-to-date, FXG has returned approximately 1.03% and is down about -3.4% over the last 12 months as of September 11, 2025. The fund has traded between $61.21 and $70.06 in the past 52 weeks [11]. - FXG has a beta of 0.57 and a standard deviation of 12.82% over the trailing three-year period, indicating medium risk with more concentrated exposure than its peers [11]. Alternatives - Other ETFs in the Consumer Staples space include the Vanguard Consumer Staples ETF (VDC) and the Consumer Staples Select Sector SPDR ETF (XLP), which have significantly larger asset bases of $7.46 billion and $15.98 billion, respectively, and lower expense ratios of 0.09% and 0.08% [13].